ADDITION OF LENALIDOMIDE TO R‐CHOP (R2CHOP) IMPROVES OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FIRST REPORT OF ECOG‐ACRIN1412 A RANDOMIZED PHASE 2 US INTERGROUP STUDY OF R2CHOP VS R‐CHOP

ADDITION OF LENALIDOMIDE TO R‐CHOP (R2CHOP) IMPROVES OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FIRST REPORT OF ECOG‐ACRIN1412 A RANDOMIZED PHASE 2 US INTERGROUP STUDY OF R2CHOP VS R‐CHOP

Saved in:
Bibliographic Details
Published in:Hematological oncology Vol. 37; no. S2; pp. 37 - 38
Main Authors: Nowakowski, G.S., Hong, F., Scott, D.W., Macon, R., King, R.L., Habermann, T.M., Wagner‐Johnston, N., Casulo, C., Wade, J.L., Nagargoje, G.G., Reynolds, C.M., Cohen, J.B., Khan, N., Amengual, J., Richards, K.L., Little, R.F., Leonard, J.P., Friedberg, J.W., Kostakoglu, L., Kahl, B.S., Witzig, T.E.
Format: Journal Article
Language:English
Published: Chichester Wiley Subscription Services, Inc 01-06-2019
Subjects:
B-cell lymphoma
Immunotherapy
Lymphocytes B
Lymphoma
Targeted cancer therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.6_2629